Efficacy of Mirogabalin (DS-5565) on Patient-Reported Pain and Sleep Interference in Patients with Diabetic Neuropathic Pain: Secondary Outcomes of a Phase II Proof-of-Concept Study

Efficacy of Mirogabalin (DS-5565) on Patient-Reported Pain and Sleep Interference in Patients with Diabetic Neuropathic Pain: Secondary Outcomes of a Phase II Proof-of-Concept Study Article Proceedings Paper

authors

Vinik, Aaron I.

publication date

November 1, 2017

webpage

Web of Science

published in

PAIN MEDICINE Journal

keywords

Mirogabalin
Neuropathy
Neuropathy Clinical Trials
Pain
Secondary Diabetic Complications
Sleep

start page

2198

end page

2207

volume

18

issue

11